Ohh M - Search Results

1

The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.

Qi H, Ohh M. Qi H, et al. Among authors: ohh m. Cancer Res. 2003 Nov 1;63(21):7076-80. Cancer Res. 2003. PMID: 14612498

2

Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex.

Maynard MA, Qi H, Chung J, Lee EH, Kondo Y, Hara S, Conaway RC, Conaway JW, Ohh M. Maynard MA, et al. Among authors: ohh m. J Biol Chem. 2003 Mar 28;278(13):11032-40. doi: 10.1074/jbc.M208681200. Epub 2003 Jan 21. J Biol Chem. 2003. PMID: 12538644 Free article.

3

Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.

Maynard MA, Ohh M. Maynard MA, et al. Among authors: ohh m. Am J Nephrol. 2004 Jan-Feb;24(1):1-13. doi: 10.1159/000075346. Epub 2003 Dec 3. Am J Nephrol. 2004. PMID: 14654728 Free article. Review.

4

Molecular cloning and characterization of the von Hippel-Lindau-like protein.

Qi H, Gervais ML, Li W, DeCaprio JA, Challis JR, Ohh M. Qi H, et al. Among authors: ohh m. Mol Cancer Res. 2004 Jan;2(1):43-52. Mol Cancer Res. 2004. PMID: 14757845

5

pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.

Stickle NH, Chung J, Klco JM, Hill RP, Kaelin WG Jr, Ohh M. Stickle NH, et al. Among authors: ohh m. Mol Cell Biol. 2004 Apr;24(8):3251-61. doi: 10.1128/MCB.24.8.3251-3261.2004. Mol Cell Biol. 2004. PMID: 15060148 Free PMC article.

6

The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.

Sufan RI, Jewett MA, Ohh M. Sufan RI, et al. Among authors: ohh m. Am J Physiol Renal Physiol. 2004 Jul;287(1):F1-6. doi: 10.1152/ajprenal.00424.2003. Am J Physiol Renal Physiol. 2004. PMID: 15180922 Free article. Review.

7

Expression of p53 in renal carcinoma cells is independent of pVHL.

Stickle NH, Cheng LS, Watson IR, Alon N, Malkin D, Irwin MS, Ohh M. Stickle NH, et al. Among authors: ohh m. Mutat Res. 2005 Oct 15;578(1-2):23-32. doi: 10.1016/j.mrfmmm.2005.02.016. Epub 2005 Jul 5. Mutat Res. 2005. PMID: 15998523

8

Molecular targets from VHL studies into the oxygen-sensing pathway.

Maynard MA, Ohh M. Maynard MA, et al. Among authors: ohh m. Curr Cancer Drug Targets. 2005 Aug;5(5):345-56. doi: 10.2174/1568009054629672. Curr Cancer Drug Targets. 2005. PMID: 16101382 Review.

9

Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma.

Maynard MA, Evans AJ, Hosomi T, Hara S, Jewett MA, Ohh M. Maynard MA, et al. Among authors: ohh m. FASEB J. 2005 Sep;19(11):1396-406. doi: 10.1096/fj.05-3788com. FASEB J. 2005. PMID: 16126907

10

Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway.

Chung J, Roberts AM, Chow J, Coady-Osberg N, Ohh M. Chung J, et al. Among authors: ohh m. Oncogene. 2006 May 18;25(21):3079-83. doi: 10.1038/sj.onc.1209328. Oncogene. 2006. PMID: 16407835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page